Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ANI Pharmaceuticals Inc
ANIP | US
80.14
USD0.20
0.25%
ANIP | US
About ANI Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
22/04/2026
Close
80.14
Open
80.35
High
81.99
Low
79.29
ANI Pharmaceuticals Inc. a biopharmaceutical company develops manufactures and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances oncology products hormones and steroids injectables and other formulations including extended release and combination products. The company manufactures oral solid dose products; semi-solids liquids and topicals; and potent products as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains wholesalers distributors and mail order pharmacies and group purchasing organizations. ANI Pharmaceuticals Inc. was incorporated in 2001 and is headquartered in Baudette Minnesota.
View LessANIP | US
Risk
33.1
Sharpe
0.35
Luna's Score
58/100
Recommendation
Hold
Luna says (ANIP | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Smallcap (300M - 2B USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
30.2%1 month
33.1%3 months
32.0%6 months
33.4%Returns
Fundamental Ratios
PE
50.68
Fwd. PE
9.89
Price to book
2.78
Debt to equity
0.68
Debt to assets
0.34
Ent. to EBITDA
11.41
Ent. to rev.
2.47
PEG
1.06
Other Fundamentals
EBITDA
107.97M
MarketCap
1.69B
MarketCap(USD)
1.69B
Div. yield
-
Op. margin
6.54
Erngs. growth
1.38K
Rev. growth
18.40
Ret. on equity
5.90
Short ratio
5.11
Short perc.
14.01
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
6.55
Range1M
9.80
Range3M
16.82
Volumes: Market Activity
Rel. volume
0.67
Price X volume
16.94M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 11.41 | - | Expensive |
| Ent. to Revenue | 2.47 | - | Cheaper |
| PE Ratio | 50.68 | 41.03 | Expensive |
| Price to Book | 2.78 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 31.97 | - | Lower Risk |
| Debt to Equity | 0.68 | -1.23 | Expensive |
| Debt to Assets | 0.34 | 0.25 | Expensive |
| Market Cap | 1.69B | - | Emerging |
